Candel Therapeutics Inc (CADL) returns
Candel Therapeutics returns over 5 years
$1,000 invested in Candel Therapeutics five years ago was worth $741.76 at the close on October 30, 2026, with dividends reinvested: an average return of -5.8% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -20.2% | — | $797.89 | -0.9% |
| 3 months | -15.6% | — | $843.97 | +2.1% |
| Year to date | +47.4% | — | $1,474 | +11.7% |
| 1 year | +49.3% | — | $1,493 | +12.4% |
| 3 years | +837.0% | +110.8% | $9,370 | +88.5% |
| 5 years | -25.8% | -5.8% | $741.76 | +76.0% |
Candel Therapeutics return by calendar year
| Year | CADL | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +47.4% | +11.7% | +35.7% |
| 2025 | -34.9% | +17.7% | -52.6% |
| 2024 | +490.5% | +24.9% | +465.6% |
| 2023 | -17.9% | +26.2% | -44.1% |
| 2022 | -77.1% | -18.2% | -58.9% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Candel Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.